Key Events This Week
8 June: Stock opens week at Rs.546.65, down 1.31% amid Sensex decline
10 June: Intraday high surge of 7.55% to Rs.587.5
11 June: New 52-week high at Rs.606.2
12 June: New 52-week high extended to Rs.629, closing at Rs.622.95

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 629
2026-06-12 09:48:55With a decisive surge to Rs 629 on 12 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally is underpinned by a confluence of bullish technical indicators and sustained gains over the past week, setting the stock apart in the Pharmaceuticals & Biotechnology sector.
Read full news article
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 606.2
2026-06-11 09:44:22With a decisive surge to Rs 606.2 on 11 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This advance comes amid a three-day winning streak that has propelled the stock up by 10% over this short span, outpacing its sector by 1.25% today alone.
Read full news article
Akums Drugs & Pharmaceuticals Ltd Surges 7.55% to Day's High of Rs 587.5 — Outperforms Sector by 6.4 Percentage Points
2026-06-10 14:31:26The Sensex advanced 0.53% on 10 Jun 2026, yet Akums Drugs & Pharmaceuticals Ltd outpaced the broader market with a robust 7.55% gain, reaching an intraday high of Rs 587.5. This 6.4 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Akums Drugs & Pharmaceuticals Ltd is Rated Hold
2026-06-08 10:10:04Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Akums Drugs & Pharmaceuticals Ltd is Rated Hold
2026-06-07 10:10:05Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-06-03 08:07:09Akums Drugs & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest improving investor sentiment and potential upside in the near term. The company’s recent upgrade from a Sell to Hold rating, alongside positive signals from MACD, Bollinger Bands, and moving averages, marks a significant change in its technical outlook within the Pharmaceuticals & Biotechnology sector.
Read full news article







